FINStruct 2023 Annual meeting will be held on 13.10.2023 at Biocity, Joki Presidentti-auditorium Tykistökatu 6, Turku, at 9:00-17:00. The event consists of talks by invited speakers, young scientists and companies as well as a poster session to present your work and meet the staff of various core facilities.
Time: 13.10.2023, at 9:00-17:00
Venue: Biocity, Joki Presidentti-auditorium, Tykistökatu 6, Turku
Registration: The event is free of charge. Registration is required: deadline 3.10.2023 (see website)
FINStruct is the Structural Biology Platform of Biocenter Finland and coordinates all research infrastructure requirements of the national structural biology network. It provides integrated structural biology services and training to support research and innovation in life sciences. FINStruct services are provided by core facilities at five universities (Helsinki, Oulu, Eastern Finland, Turku, and Åbo Academi), and coordinated by the University of Helsinki.
Instruct-ERIC Centre Finland is a national node of Instruct-ERIC, one of the operators at the European Strategy Forum on Research Infrastructures (ESFRI).
Register now for the Single Cell Omics symposium,
Oct 26 to 27, 2023, in Biomedicum Helsinki.
The symposium covers broad areas of single cell omics: from spatial interactions to epigenetic plasticity, with methodologies ranging from functional genomic screens to machine learning models, applied in a wide range of biological contexts: intestinal stem cells, brain development, immunology and cancer.
Program begins at 9 AM on Oct-26, and ends at 1PM on Oct-27. We will have a poster session on Oct-26 after the talks.
The symposium is on-site only, free of charge and everybody is warmly welcome to register!
Barbara Treutlein (ETH Zurich), Oliver Stegle (EMBL Heidelberg) , Kelley Yan (Columbia University), Brian Cleary (Boston University College of Engineering), Valentina Boeva (ETH Zurich), Celine Vallot (Institut Curie), Jessica Nordlund (Uppsala University), and Mark Robinson (University of Zurich), will present their work, in addition to national speakers Sakari Vanharanta (University of Helsinki), Tuure Kinnunen (University of Eastern Finland), Pia Rantakari (University of Turku), and Satu Mustjoki (University of Helsinki).
Symposium is part of the Single Cell Course week 2023 with hands-on wet-lab and data-analysis courses for students.
Organising team: Anna Vähärautio, Pirkko Mattila, Saara Ollila, Kati Donner, Minna Kaikkonen-Määttä, Merja Heinäniemi, Virpi Ahola, Asta Laiho, Tapio Lönnberg, Laura Elo, Eija Korpelainen.
Letter of Intent - Biocenter Finland SAB 2024 Evaluation
Biocenter Finland (BF, https://www.biocenter.fi/) is a nation-wide Life Science research infrastructure jointly hosted by University of Eastern Finland (UEF), University of Helsinki (UH), University of Oulu (UO), Tampere University (TAU), University of Turku (UTU) and Åbo Akademi University (ÅAU). BF Platforms support frontier research by providing open-access technology services. Currently BF has 15 Technology Platforms and each Platform functions as a network of distributed Nodes in several host universities with clearly defined complementary tasks. BF’s investment resources are applied for from the Research Infrastructure Calls (FIRI Calls) of the Academy of Finland – Finnish Research Council, while the Platforms’ key personnel’s salary costs and the Coordination Office’s costs are covered by the host universities.
The Academy of Finland will organize the next FIRI Roadmap call 2025-2028 most likely in spring 2024. The Technology Platforms are selected to BF for four-year period based on Scientific Advisory Board (SAB) recommendation. The selected organization of BF Platforms will then be used in the next BF’s FIRI Roadmap application for Academy of Finland.
BF invites applications for Technology Platforms for 2025-2028. The call will be open to existing Platforms, new Platform openings and inclusion of new nodes to existing Platforms.
Important details about the BF SAB 2024 Evaluation:
Call for Letter of Intent (LoI)
Both existing platforms and new platform initiatives are requested to send the LoI application. For more details, please contact: biocenterfinland (at) helsinki.fi. Letter of Intent period is open 14.8. – 7.9.2023. The BF Board will evaluate the LoI’s and give feedback to applicants before the call of full applications.
Call for full applications
The Platforms are invited to provide full applications describing the composition of the Platform, the services provided and competence including e.g. user statistics (for existing Platforms coordination office will provide the relevant reported data). The application period will be open 16.10.-1.12.2023. BF office will organize an information event before the full call, where the call details will be discussed.
SAB evaluation / interviews
The on-site interviews and evaluation of the Platforms by the SAB will be organized on 5.-7.2.2024 in Helsinki. More information about the schedule will be provided in the autumn. The evaluation results and report of SAB will be available on early-March 2024 after which BF Board will make decisions.
If you have any questions, do not hesitate to contact us: biocenterfinland (at) helsinki.fi.
Join us at the upcoming Bridging Cancer Frontiers Symposium, a unique gathering focusing on cutting-edge cancer research and insights. Scheduled for August 29-31, 2023, at the Pharmacity Auditorium, Turku, Finland.
Important Notice: Registration deadline is approaching quickly! Although the symposium has no attendance fee, we kindly encourage you to register as soon as possible for catering arrangements during the breaks. Additionally, there's a special Jacobaeus Prize Concert and Dinner on Wednesday, Aug. 30, at 18:30 in Turku Castle. Make sure to register for both the symposium and dinner by Aug 15 using the links below:
Symposium Highlights: Over the course of three eventful days, the symposium will provide:
- Comprehensive overviews of current research.
- Discussions from leading cancer researchers, including Douglas Hanahan and Sir David Lane, with David Lane being honored with the Jacobaeus Prize from the Novo Nordisk Foundation.
- Focused sessions on metabolic signaling pathways, HPV-mediated cancers, the role of AI in cancer research, and more.
For a full agenda and regular updates, please refer to the symposium's official web page.
Bridging Cancer Frontiers - Not just a symposium – it's the collective mission of life science researchers.
Come to learn how YOUR RESEARCH could benefit from the chemical biology and drug discovery tools available in Finland!
Date and time: May 4, 2023 between 12:00-16:00.
Place: Lecture hall 2, Biomedicum 1, Helsinki.
Format: hybrid (on site or remotely)
Online translation link (Zoom) will be provided to registered participants a few days prior to the event.
Registration: by April 15 (registration link)
Prof. Päivi Tammela, University of Helsinki
Dr. Michael Courtney, Turku Bioscience Centre, University of Turku and Åbo Academy University
Laxman Yetukuri, CSC – IT CENTER FOR SCIENCE LTD
Find out more:
Symposium's web page
DDCB consortium web page
FIMM High Throughput Biomedicine Unit (HTB)
HTB LinkedIn page
EIPOD-LinC is a Postdoctoral fellowship programme supporting promising researchers from around the world who are passionate about interdisciplinary research. The programme is designed to support the increasing diversity of career paths in Europe’s research landscape providing researchers with the mentoring, training and career development support needed to become leaders in academia, industry and beyond.
The programme is embedded in EMBL’s unique interdisciplinary and collaborative research environment. Candidates work on self-designed interdisciplinary research projects in the context of EMBL’s research programme: Molecules to Ecosystems. All projects require an EMBL Host and a partner. Partners may come from EMBL or from an academic institute, industry or clinic located in an EMBL Member State, Associate Member State or Prospect Member State. Importantly, projects must allow candidates to gain new skills contributing to interdisciplinary research skill sets.
Call deadline: January 18th, 2023.
More information: https://www.embl.org/about/info/postdoctoral-programme/eipod-linc-exploring-life-in-context/eipod-linc-application/.
Director of Biocenter Finland, Professor Olli Silvennoinen, has been nominated as Finland’s delegate in the European Molecular Biology Laboratory (EMBL) Council and the European Molecular Biology Conference (EMBC) Council: https://okm.fi/paatos?decisionId=0900908f807ea443.
More information about EMBL council: https://www.embl.org/about/info/embl-council/, and EMBC: https://embc.embo.org/.
Frontiers of Science is a 25-year-old seminar series arranged by BioCity Turku, where BioCity Turku researchers invite world-leading scientists to give a talk and present their latest results from their field of research. The seminars are intended for both researchers and students and students can get ECTs from participation.
- We are happy to be able to arrange again all the Frontiers of Science seminars on-site. Lectures won’t be recorded nor broadcasted, so the only way to listen to these great talks is to come in person and meet your colleagues, says Professor Klaus Elenius, Scientific Director of BioCity Turku.
- Also we decided to move a bit away from BioCity neighborhood and since we have plenty of BioCity Turku research groups working in Aurum, we wanted to arrange the December seminar in Argentum auditorium. The December lecture is dealing with computing, data and energy production that are topics, which surely interests many of us, Elenius continues.
Take a look at the full Frontiers of Science seminar program from here: https://biocityturku.fi/autumn-2022-programme/
Student, have a face-to-face lunch with a world-leading scientist!
Frontiers of Science seminars are on Thursdays at 12:00.
The seminars are arranged either in BioCity, Presidentti auditorium (October and November) or in Aurum, Argentum auditorium (December). There is no registration to the on-site events and there is coffee and sandwich served before the seminar.
If you are a student and wish to collect ECTs, please print the Seminar Diary and ask the coordinator to sign it after the seminar.
Print the Seminar Diary from here:
Download and add all the Frontiers of Science seminars to your calendar:
Take a look at the poster from here:
More information from Frontiers of Science seminars:
Any questions? Just ask!
Prof. Aled Clayton, Cardiff University, UK
How do extracellular vesicles work?
CANCELLED: October 13th
Ana Teixeira, Karolinska Institutet, Sweden
Mapping and targeting membrane protein nanodomains
Prof. Gilles van Wezel, Leiden University, Netherlands
Ecology-inspired approaches towards antibiotic discovery in Actinobacteria
Prof. Jacques Neefjes, Leiden University Medical Center, Netherlands
Detoxifying anthracycline anti-cancer drugs for new treatment options of relapsed cancer patients
Prof. Christian Wolfrum, ETH Zürich, Switzerland
Adipocyte plasticity and its impact on metabolism
Prof. Johanna Myllyharju, University of Oulu, Finland
Prolyl 4-hydroxylation – a druggable protein modification with central roles in collagen synthesis and regulation of hypoxia response
Frontiers of Science meets Aurum!
Prof. Gianfranco Pacchioni, Università degli Studi di Milano-Bicocca, Italy
Computer driven material discovery
The organizing teams the Biomedicum Helsinki and Viikki Monday seminars have joined forces to offer you science for lunch on Mondays! HiLIFE webinars continue the tradition of inviting outstanding, international scientists to present their work to the broad audience of the life science community during the extraordinary circumstances that restrict travel and personal contact.
Date: Mondays at 13.00 noon Helsinki time (time can vary, check the details of each webinar)
Place: Link of place can be found in the details of each talk
Twitter #hilifewebinars #bmhsem #viikkimon
Professor of Medical Biochemistry Klaus Elenius from the University of Turku has been selected for the position of the Scientific Director of BioCity Turku, a member Institute in Biocenter Finland. The vacancy lasts five years and started on 1 January 2022. BioCity Turku is a joint organisation of the University of Turku and Åbo Akademi University, supporting and coordinating bioscience research in the Turku region.
Picture: Suvi Harvisalo
For more information, see:
The Structural Biology Finland Conference 2021 highlights the official opening of the Instruct-ERIC Centre Finland, show-casing the latest scientific highlights in integrated structural cell biology and demonstrating the use of key research infrastructure available in the Instruct-ERIC and FINStruct service catalogues. Participants can present posters, flash talks and give industrial exhibitions.
Instruct-ERIC Centre Finland and Structural Biology Finland (FINStruct) organize a Conference Instruct-ERIC Centre Finland Opening and Structural Biology Finland Conference 2021 on December 17, at 8.45-17:45 EET in Viikki Info Center.
The event is organized as a hybrid meeting and can be joined remotely. Due to the coronavirus epidemic, the event will be organized in accordance with the guidelines and restrictions of University of Helsinki in effect at the time of the event.
December 17, at 8.45-17:45 EET
Viikki Info Center, Oppimistori, Viikinkaari 11, Helsinki;
Information about Viikki Campus, public transportation, car parking etc.
Registration is required: deadline December 3rd, 2021
Please register here.
Registration is free of charge
A link will be provided for participants who register for online event
Please comply with the University of Helsinki guidelines to prevent the spread of Sars-Cov2
Please attend on site only if you are completely healthy.
Sarah Butcher, Director, FINStruct and Instruct-ERIC Centre Finland (University of Helsinki)
Hanna Oksanen, Coordinator, FINStruct and Instruct-ERIC Centre Finland (University of Helsinki; for contact: hanna.oksanen(at)helsinki.fi)
FINStruct and Instruct-ERIC Centre Finland core facility group leaders: Lari Lehtiö, Juha Rouvinen, Minna Poranen, Hideo Iwai, Tommi Kajander, Markku Varjosalo, Tiina Salminen, Tassos Papageorgiou (Universities of Helsinki, Oulu, Eastern Finland, Turku and Åbo Akademi University)
Sergei Gurianov (University of Helsinki)
Biocenter and Helsinki Institute of Life Science HiLIFE organize a Symposium: Life Sciences Combatting Global Challenges - The European perspective. on November 26 at 10-12.
Keynote by Prof Ewan Birney: EMBL: Europe’s international life science laboratory - from viruses to ecosystems
Director of EMBL-EBI & Deputy Director General of EMBL
Pauli Kallio, Katja Kivinen and
See details below.
Welcome to the Symposium!
Life Sciences are central to understanding the most pressing global challenges from climate change and loss of biodiversity to pandemics and other severe health care challenges. The ongoing rapid technological and digital developments are providing tools to address these challenges in completely new ways with direct applications in environment, agriculture, health care, innovations and industry. The technology-driven revolution in Life Sciences underline the importance of modern infrastructure services.
Biocenter Finland and Helsinki Institute of Life Science HiLIFE organize a Symposium Life Sciences Combatting Global Challenges - The European perspective on November 26, at 10 AM-12 PM in Viikki Infocenter. The Symposium is organized as a hybrid meeting and can be joined remotely.
Professor Ewan Birney, Director of EMBL-EBI and Deputy Director General of EMBL gives the Keynote Lecture on the EMBL research and infrastructure organization. The Keynote covers the new EMBL Scientific Programme and European response to the COVID-19 pandemic. The Symposium includes presentations from prominent Finnish Life Science researchers and experts and a panel discussion on Life Science research and infrastructures in the European context.
Time: November 26, at 10 AM-12 PM
Venue: Viikki Infocenter, Oppimistori;
Viikinkaari 11, Helsinki
Arrival: See map included with the programme. Limited parking lots available due to Raide Jokeri construction work in Viikinkaari. Few general parking lots at campus and more at nearby Prisma shopping center
Registration: Registration is required for those attending the Symposium onsite https://www.lyyti.fi/reg/LS_Combatting_Global_Challenges
Remote access: https://helsinki.zoom.us/j/67905842883, (passcode 808666)
Safety: Please comply with the University of Helsinki guidelines to prevent the spread of Sars-Cov2
Click here for full programme!
The Nordic EMBL Partnership warmly invites you to participate in the tenth Building Bridges symposium providing an exciting collaborative look into advanced research technologies. The Building Bridge series is aimed to highlight collaborative efforts towards, ultimately, a better understanding of the pathophysiology of disease and improved options for patient treatment and care.
Building Bridges 2021: Technologies advancing molecular medicine – focus on Nordic infrastructures
The Building Bridges symposia series is arranged to bridge basic, translational and clinical research and provide examples of how teams of investigators are working together to advance molecular medicine. With the 10th Building Bridges symposium we shine the spotlight on technologies used to improve our understanding of health and disease. In particular, we will demonstrate research advances using infrastructure available in the Nordic region, bridging research and technology development as well as bridging researchers across borders. With an opening and closing keynote from EMBL Heidelberg and EMBL Hamburg, we highlight research infrastructure at EMBL, as well.
Join the symposium and learn more about the research technology and core facility services available within the Nordic EMBL Partnership!
Organizers: The Nordic EMBL Partnership for Molecular Medicine, a Nordforsk-funded Research Infrastructure Hub. The Nordic EMBL Partnership consists of four international research and technology centers:
- Danish Research Institute of Translational Neuroscience (DANDRITE)
- Institute for Molecular Medicine Finland (FIMM)
- The Laboratory for Molecular Infection Medicine Sweden (MIMS)
- Centre for Molecular Medicine Norway (NCMM)
On-site: University of Helsinki, Meilahti Campus, Biomedicum 1, Lecture Hall 2
Online via Zoom: link and passcode provided in registration confirmation
Date and time: Wednesday, 1 December 2021 at 9:00-16:00 CET/10.00-17.00 EET
Welcome from the organizers & setting the stage
Katja Kivinen, FIMM
Session I: High resolution technologies in molecular medicine
Chairs: Pirkko Mattila, FIMM
Opening Keynote: From genotype to phenotype with single-cell resolution
Oliver Stegle (DKFZ & EMBL Heidelberg)
Single cell analysis for precision cancer medicine
Caroline Heckman (FIMM)
Discovery of novel anti-chlamydial compounds through a multi-strategy screening approach
Barbara Sixt (MIMS)
Break, coffee & tea
Aarhus CryoEM - on the path to in situ structural biology
Thomas Boesen (DANDRITE)
Inherited causes of somatic mutagenesis and evolution in cancer
Sebastian Martin Waszak (NCMM)
Short pitches for research visits
CryoEM structures of centromeric complexes – collaboration between NCMM and cryoEM facility in Umeå (MIMS)
Ahmad Ali-Ahmad (NCMM)
Defining dietary effects on mouse gut microbiota metabolites with metabolomics
Björn Schröder (MIMS) & Anni Nieminen (FIMM)
Patient-derived slice-model as a low throughput screening method
Nanna Møller Jensen (DANDRITE)
Collaborations with Chemical Biology Consortium Sweden (CBCS): The Swedish national platform for small molecule screening
Anna Eriksson (CBCS)
Phenotypic screening of patient -derived primary cells (FIMM-NCMM collaboration)
Antti Hassinen (FIMM)
Lunch (light lunch provided for those attending on-site)
Session II: Models, characterizations and structures
Chair: Thomas Boesen (DANDRITE)
Diagnostic modelling in the context of cancer heterogeneity
Emmy Verschuren (FIMM) & Sarang Talwelkar (FIMM)
Unbiased characterization of cells using single-cell analysis
Johan Henriksson (MIMS)
The zebrafish as a model organism to understand and treat complex genetic disorders
Camilla Esguerra (NCMM)
Break, coffee & tea
Lipid flippase CryoEM structure case: structure-based drug development and translational collaboration with hospitals/medical doctors
Thibaud Dieudonne (DANDRITE)
Closing keynote: EMBL Imaging Centre: the technology development we need for the imaging challenges we face
Simone Mattei (EMBL Hamburg)
Organizing committee led by Katja Kivinen
ECTS credits: 1,0 ECTS - University of Helsinki doctoral candidates who would like to earn 1,0 ECTS are required to attend the symposium and complete advance readings and follow-up quiz questions provided for each talk. Further information about the advance readings and quiz will be posted on the course webpage as soon as available.
University of Helsinki doctoral candidates must register in SISU, course code DPBM-194
All others, please register using the e-form: https://elomake.helsinki.fi/lomakkeet/53957/lomake.html
Registration deadline: 21 November
Biocenter Finland's Annual Report 2020 has been published. Read more here.
Preclinical studies using animal models are an integral part of biomedical research. However, their value is dependent on their scientific validity and reproducibility , which are, in turn, dependent on rigorous study design and reporting. This symposium aims to update on the guidelines developed and recommended for achieving robust research output
When: November 10, 2021; 12:30 17:00 EET (Finland)
Where: Zoom meeting.
Registration: for this meeting is required and open until 14:00 on November 8.
Please use the e form for registration https://elomake.helsinki.fi/lomakkeet/113272/lomake.html
Link for joining the meeting will be sent to the email of registered participant on November 9.
Organizers: Finnish Reproducibility Network and HiLIFE Comprehensive Model Organisms infrastructure platform